查看購物車
  • Simplified Chinese
  • English
中東和非洲轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶
市場調查報告書
商品編碼
1562245

中東和非洲轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶

Middle East & Africa Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

2022年中東及非洲轉染試劑及設備市場價值為4,615萬美元，預計2030年將達8,053萬美元；預計 2022 年至 2030 年複合年成長率為 7.2%。

細胞和基因治療的日益普及提振了中東和非洲轉染試劑和設備市場

細胞和基因療法的製造是一個複雜的過程，這使得其執行和監控至關重要。生物技術的進步導致採用個人化治療來治療多種適應症。細胞和基因療法主要用於治療神經系統疾病、癌症和遺傳性疾病等慢性疾病。細胞和基因療法的顯著優勢包括標靶治療、更快、更有效的恢復以及減少副作用。由於獲得美國食品和藥物管理局 (FDA) 批准的產品，細胞和基因療法在世界各地已廣泛採用。例如，FDA 於2022 年批准了Ferring Pharmaceuticals A/S 生產的腺病毒ADSTILADRIN。些類型膀胱癌的患者。 2022年，楊森生物技術公司生產的CARVYKTI也獲得FDA核准。 CARVYKTI 是一種以慢病毒改造的自體 CAR-T 細胞，可攻擊表達 BCMA 的腫瘤細胞，用於治療某些類型的復發或難治性多發性骨髓瘤。如今，科學家正採用轉染技術來生產這些療法。因此，細胞和基因治療活動的普及推動了轉染程序的數量增加，進而推動了中東和非洲轉染試劑和設備市場的成長。

中東和非洲轉染試劑和設備市場概況

中東和非洲地區分為沙烏地阿拉伯、南非、阿拉伯聯合大公國以及中東和非洲其他地區。 2022 年，沙烏地阿拉伯將佔據最大的市場佔有率。

中東和非洲製藥業的成長廣泛受到跨國製藥公司在沙烏地阿拉伯、南非、阿拉伯聯合大公國等國家的投資的推動。 2023年1月，沙烏地阿拉伯投資部簽署了兩份合作備忘錄，以改善與沙烏地阿拉伯生物技術和醫藥產業的聯合合作。該部與德國勃林格殷格翰公司簽署了一項協議，以加強製藥業。第二份合作備忘錄是與諾和諾德沙烏地阿拉伯和阿卜杜拉國王科技大學簽署的，旨在為提高社區對代謝紊亂、肥胖和糖尿病概念的認知提供解決方案。這些讓人們了解罕見和慢性疾病的努力可能會在未來幾年提振沙烏地阿拉伯的轉染試劑和設備市場。

此外，這些國家公司之間的合作夥伴關係推動了市場成長，2021 年12 月，Secondcell Bio 和Alliance Care Technologies International 宣佈建立新的策略合作夥伴關係，建立一個新穎的尖端研究設施，專注於細胞治療和快速藥物發現，以對抗罕見疾病阿拉伯聯合大公國的遺傳疾病。 Chromovert 技術遠遠領先於 CRISPR，它具有廣泛的潛力，可以透過產生先前為改進藥物發現而設計的細胞來簡化藥物發現過程。

中東和非洲轉染試劑和設備市場收入及2030年預測（百萬美元）

中東和非洲轉染試劑和設備市場細分

中東和非洲轉染試劑和設備市場根據產品、方法、應用、最終用戶和國家進行細分。

根據產品，中東和非洲轉染試劑和設備市場分為試劑和儀器。 2022 年，試劑細分市場將佔更大佔有率。

從方法來看，中東和非洲轉染試劑和設備市場分為病毒法、非病毒法和混合法。 2022 年，非病毒方法部分佔最大佔有率。非病毒部分分為物理/機械方法和化學方法。此外，物理/機械方法細分為電穿孔、顯微注射、生物彈體方法、雷射方法、磁轉染和聲穿孔。此外，化學方法部分又分為基於脂質體/高脂質和基於非脂質體/高脂質。

按應用分類，中東和非洲轉染試劑和設備市場分為生物醫學研究、蛋白質生產和治療遞送。 2022 年，生物醫學研究領域佔最大佔有率。

根據最終用戶，中東和非洲轉染試劑和設備市場分為學術和研究機構以及製藥和生物技術公司。 2022 年，學術和研究機構領域佔據了更大的佔有率。

按國家分類，中東和非洲轉染試劑和設備市場分為南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區。 2022年，沙烏地阿拉伯在中東和非洲轉染試劑和設備市場佔據主導地位。

Thermo Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG 和 MaxCyte Inc 是中東地區的一些領先公司&非洲轉染試劑及設備市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：中東和非洲轉染試劑和設備市場 - 主要市場動態

  • 中東和非洲轉染試劑和設備市場 - 主要市場動態
  • 市場促進因素
    • 細胞和基因療法越來越受歡迎
    • 癌症帶來的經濟負擔日益沉重
  • 市場限制
    • 儀器及耗材成本高
  • 市場機會
    • 將小規模流程升級為大規模流程
  • 未來趨勢
    • 公司的策略舉措
  • 促進因素和限制的影響：

第 5 章：轉染試劑和設備市場 - 中東和非洲市場分析

  • 2022-2030年中東和非洲轉染試劑和設備市場收入
  • 中東及非洲轉染試劑及設備市場預測分析

第 6 章：中東和非洲轉染試劑和設備市場分析 - 按產品

  • 試劑
  • 裝置

第 7 章：中東和非洲轉染試劑和設備市場分析 - 依方式

  • 病毒性的
  • 非病毒性
  • 混合

第 8 章：中東和非洲轉染試劑和設備市場分析 - 按應用

  • 生物醫學研究
  • 蛋白質生產
  • 治療實施

第 9 章：中東和非洲轉染試劑和設備市場分析 - 按最終用戶

  • 學術及研究機構
  • 製藥和生物技術公司

第 10 章：中東和非洲轉染試劑和設備市場 - 國家分析

  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 無機成長策略
  • 有機成長策略

第 11 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc

第 12 章：附錄

Product Code: BMIRE00030478

The Middle East & Africa transfection reagents and equipment market was valued at US$ 46.15 million in 2022 and is expected to reach US$ 80.53 million by 2030; it is estimated to register at a CAGR of 7.2% from 2022 to 2030.

Increasing Popularity of Cell and Gene Therapy Bolsters Middle East & Africa Transfection Reagents and Equipment Market

Cell and gene therapy manufacturing is a complicated process, which makes its execution and monitoring critical. Advancements in biotechnology have led to the adoption of personalized treatments for the treatment of numerous indications. Cell and gene therapies mostly are used to treat chronic diseases such as neurological disorders, cancer, and genetic disorders. The noteworthy advantages of cell and gene therapy include targeted treatment, faster and more efficient recovery, and reduced side effects. Cell and gene therapies are widely adopted across the world owing to the availability of Food and Drug Administration (FDA) approved products. For instance, the FDA approved an adenovirus ADSTILADRIN manufactured by Ferring Pharmaceuticals A/S in 2022. This recombinant adenovirus (rAd-IFNa/Syn3) delivers human interferon alfa-2b cDNA into the bladder epithelium to treat patients suffering from certain types of bladder cancer. In 2022, CARVYKTI, manufactured by Janssen Biotech, Inc., was also approved by the FDA. CARVYKTI is an autologous CAR-T cell engineered with lentivirus to attack BCMA-expressing tumor cells for the treatment of certain kinds of relapsed or refractory multiple myeloma. Scientists are nowadays employing the transfection technique for the production of these therapies. Hence, an upsurge in the popularity of cell and gene therapy activities fuels the number of transfection procedures performed, which, in turn, fuels the growth of the Middle East & Africa transfection reagents and equipment market.

Middle East & Africa Transfection Reagents and Equipment Market Overview

Middle East and Africa region is classified into Saudi Arabia, South Africa, United Arab Emirates, and Rest of Middle East and Africa. Saudi Arabia hold the largest market share in the year 2022.

The growth of the pharmaceutical industry in Middle East and Africa is widely driven by investments made by multinational pharmaceutical companies in countries such as Saudi Arabia, South Africa, United Arab Emirates, and more. In January 2023, Saudi Arabia's Ministry of Investment signed two memorandums of understanding to improve joint cooperation with the biotechnology and medicine industries in the kingdom. The ministry signed one agreement with Boehringer Ingelheim, a German company, for the enhancement of the pharmaceutical industry. The second MoU was signed with Novo Nordisk Saudi Arabia and King Abdullah University of Science and Technology with an aim to contribute to providing solutions for developing community awareness about the concepts of metabolic disorders, obesity, and diabetes. Such efforts made to make people aware of rare and chronic medical conditions are likely to bolster the transfection reagents and equipment market in Saudi Arabia in the coming years.

Furthermore, partnerships between companies in these countries propelling the market growth, in December 2021, Secondcell Bio and Alliance Care Technologies International announced a new strategic partnership for establishing a novel, cutting-edge research facility focused on cell therapy and rapid drug discovery for combating rare genetic diseases in the UAE. The Chromovert technology is far ahead of CRISPR, and it has extensive potential to streamline the drug discovery process by enabling the generation of cells that were previously designed for improved drug discovery.

Middle East & Africa Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Transfection Reagents and Equipment Market Segmentation

The Middle East & Africa transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Middle East & Africa transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Middle East & Africa transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Middle East & Africa transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Middle East & Africa transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Middle East & Africa transfection reagents and equipment market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa transfection reagents and equipment market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the Middle East & Africa transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Middle East & Africa Market Analysis

  • 5.1 Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 Middle East & Africa Transfection Reagents and Equipment Market Forecast Analysis

6. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East and Africa Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 Middle East and Africa
    • 10.1.1 Middle East and Africa Transfection Reagents and Equipment Market Overview
    • 10.1.2 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.1 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.2 Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.2.2.3 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.2.2.4 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.2.3 South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.2.3.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.3.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.3.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.3.2.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.3.2.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.2.3.3 South Africa: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.2.3.4 South Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.2.4 United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.2.4.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.4.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.4.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.4.2.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.4.2.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.2.4.3 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.2.4.4 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.2.5 Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.2.5.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.5.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.5.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.5.2.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.5.2.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.2.5.3 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.2.5.4 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
  • 10.2 Inorganic Growth Strategies
    • 10.2.1 Overview
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview

11. Company Profiles

  • 11.1 Thermo Fisher Scientific Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Promega Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 F. Hoffmann-La Roche Ltd
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Bio-Rad Laboratories Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Mirus Bio LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 QIAGEN NV
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Merck KGaA
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Lonza Group AG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 MaxCyte Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us

List Of Tables

  • Table 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation
  • Table 2. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 38. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 39. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 40. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 41. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 42. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 43. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 44. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 45. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Middle East and Africa: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)